Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study

Autor: Jean Bousquet, Neil Barnes, Michael Gibbs, Nadeem Gul, Susan A Tomkins, Xin Zhou, Young-Joo Cho, Hae-Sim Park, William Busse, Nanshan Zhong

Publikováno v: BMC Pulmonary Medicine, Vol 17, Iss 1, Pp 1-12 (2017)

Abstract Background To analyse the efficacy of fluticasone propionate (FP) alone and combined with salmeterol (SAL) in achieving guideline-defined asthma control in Asian patients. Methods A post hoc analysis of the GOAL study in which patients were

Externí odkaz: https://doaj.org/article/1b57930019464b279e8c59e559ad5f2e

A randomized, double-blind, placebo-controlled, parallel-group study of once-daily inhaled fluticasone furoate on the hypothalamic-pituitary-adrenocortical axis of children with asthma

Autor: Mohammed Tayob, Rashmi Mehta, Philippe Bareille, Varsha Imber, Susan A. Tomkins, Sanjeev Khindri, Karen Dunn

Publikováno v: Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Allergy, Asthma & Clinical Immunology, Vol 16, Iss 1, Pp 1-9 (2020)

Background To evaluate the effects of fluticasone furoate on the hypothalamic–pituitary–adrenocortical axis, and the safety and tolerability of fluticasone furoate treatment in children with asthma. Methods This was a randomized, double-blind, pl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::312106c1234f66ccf9536a3d8f527070
https://pubmed.ncbi.nlm.nih.gov/32042286

Knemometry Assessment of Short-term Growth in Children With Asthma Receiving Fluticasone Furoate for 2 Weeks: A Randomized, Placebo-controlled, Crossover Trial

Autor: Sanjeev Khindri, Susan A. Tomkins, Philippe Bareille, Ole D. Wolthers, Sally Stone

Publikováno v: Clinical therapeutics. 39(6)

A dry powder inhaler formulation of the inhaled corticosteroid fluticasone furoate (FF) is being evaluated for use in children. An important potential risk associated with the use of inhaled corticosteroids in children is growth suppression. Therefor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d88fa0a490459da95064f52e0055c269
https://pubmed.ncbi.nlm.nih.gov/28843366

Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy

Autor: Ryan M. Klein, Ronina A. Covar, Jonathan Grigg, Christine A. Sorkness, Caroline Goldfrad, Susan A. Tomkins, Søren Pedersen, César Villarán, Amanda Oliver

Publikováno v: Oliver, A J, Covar, R A, Goldfrad, C H, Klein, R M, Pedersen, S E, Sorkness, C A, Tomkins, S A, Villarán, C & Grigg, J 2016, ' Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy ', Respiratory Research, vol. 17, 37 . https://doi.org/10.1186/s12931-016-0353-4
Respiratory Research

Inhaled corticosteroids (ICS) are effective maintenance treatments for childhood asthma; however, many children remain uncontrolled. Vilanterol (VI) is an inhaled long-acting beta-2 agonist which, in combination with the ICS fluticasone furoate, is b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f559265d7f658560aea2346633ffd56
https://findresearcher.sdu.dk:8443/ws/files/142915340/Randomised_trial_of_once_daily_vilanterol_in_children_with_asthma_on_inhaled_corticosteroid_therapy.pdf

Corrigendum to 'Knemometry Assessment of Short-term Growth in Children with Asthma Receiving Fluticasone Furoate for 2 Weeks: A Randomized, Placebo-controlled, Cross-over Trial' Clin Ther 2017;39:1191–1199

Autor: Philippe Bareille, Susan A. Tomkins, Ole D. Wolthers, Sally Stone, Sanjeev Khindri

Publikováno v: Clinical Therapeutics. 39:1904

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d1b446fc0ced4506f4125aa210f9aa3
https://doi.org/10.1016/j.clinthera.2017.08.007